Skip to content. | Skip to navigation

Personal tools
Log in
Sections
Home > Profiles > Nur Mustafaoglu

Nur Mustafaoglu

Nur Mustafaoglu

Email: Nur.Mustafaoglu.1@nd.edu

Phone: 574-631-3411

Office: A69 Fitzpatrick Hall

Education

B.S., Molecular Biology and Genetics, Istanbul Technical University, 2010

B.S., Physics Engineering, Istanbul Technical University, 2011

M.S., Nano Science and Nano Engineering, Istanbul Technical University, 2012

News

Notre Dame Researchers Are Improving the Speed and Practicality of Detecting Disease

June 15, 2017

To improve the speed and practicality of common diagnostic tests, Notre Dame researchers have been working to develop an improved test method and have recently published a study on a new method that uses gold nanoparticles, requires little to no expertise, and provides results in minutes.

Notre Dame Researchers are Improving the Speed and Practicality of Detecting Disease

June 12, 2017

Published: June 12, 2017, Author: Brandi Klingerman To detect an illness in the body, common diagnostic tests like the enzyme-linked immunosorbent assay (ELISA) are used. Unfortunately, ELISA takes hours to process and requires expert analysis, limiting its benefits for developing countries and those who require immediate results. In order to combat these challenges, Notre Dame researchers have been working to develop an improved test and have recently published a study on a new diagnostic method that uses gold nanoparticles, requires little to no expertise, and provides results in minutes.

Events

Aug 17

BioPhD Candidate Nur Mustafaoglu - "Design of Antibody-Based Diagnostics and affinity Chromatography Systems Utilizing the Nucleotide Binding Site (NBS)"

This dissertation focuses on developing advanced diagnostic systems, efficient antibody purification techniques, and novel antibody-drug conjugation methods while aiming to improve availability of antibody-based technologies to end-users. Antibodies have become widely used agents for clinical treatment of cancers and autoimmune diseases due to their high level of specificity and selectivity toward known target molecules (antigens) found to be overexpressed on cancerous cells. Despite the many techniques that utilize antibodies necessitate that they are modified in some way by conjugating functional ligands to them – endowing them with specific functionalities unique for each intended application – they are still in need of improvement.

>View more Events

Adviser(s)